- [1].
SHAHIM B,KAPELIOS CJ,SAVARESE G,et al. Global public health burden of heart failure: an updated review [J]. Card Fail Rev,2023,9: e11.
- [2].
DE JORGE-HUERTA L,MARCO-ALACID C,GRANDE C,et al. A narrative review of the diagnosis and treatment of sarcopenia and malnutrition in patients with heart failure [J]. Nutrients,2024,16(16):2717.
- [3].
NAKADE T,MAEDA D,MATSUE Y,et al. Prognostic value of sarcopenia definitions and outcomes consortium criteria in older patients with heart failure[J]. J Am Med Dir Assoc,2025,26(1):105350.
- [4].
ZUO XR,LI XH,TANG K,et al. Sarcopenia and cardiovas-cular diseases: a systematic review and meta-analysis[J]. J Cachexia Sarcopenia Muscle,2023,14(3):1183-1198.
- [5].
LIU YY,SU MY,LEI Y,et al. Sarcopenia predicts adverse prognosis in patients with heart failure: a systematic review and meta-analysis[J]. Rev Cardiovasc Med,2023,24(9):273.
- [6].
中华医学会心血管病学分会,中国医师协会心血管内科医师分会,中国医师协会心力衰竭专业委员会,等.中国心力衰竭诊断和治疗指南2024[J].中华心血管病杂志,2024,52(3):235-275.
- [7].
CORNELISSEN V,HANSSEN H,HURST C,et al. Influ-ence of exercise and nutrition on sarcopenia in cardiovascu-lar disease: a Scientific Statement of the European Associa-tion of Preventive Cardiology of the ESC[J]. Eur J Prev Cardiol,2025: zwaf432.
- [8].
李涵,孙杨,张晓雨,等.以证统病——中医临床思维的回归与创新[J].世界中医药,2019,14(10):2552-2556.
- [9].
高治理,贺娟.黄元御对《黄帝内经》脾胃理论的继承与发展[J].北京中医药大学学报,2018,41(11):890-893.
- [10].
黄元御.四圣心源[M].菩提医灯,主校.北京:中国医药科技出版社,2016.
- [11].
难经[M].孙桐,主编.北京:中国医药科技出版社,1996: 10.
- [12].
李东垣.内外伤辨惑论[M].张年顺,校注.北京:中国中医药出版社,2007: 13.
- [13].
张瑞,贾福运,闫景顺,等.基于“脾-线粒体”和“湿浊痰饮类病”学说探析心力衰竭发病与辨治[J].中国实验方剂学杂志,2025,31(10):265-274.
- [14].
崔志洁,高铸烨,姜众会,等.基于“脾主肌肉”理论探讨线粒体质量控制在心力衰竭合并肌少症中医药治疗中的价值[J].陕西中医,2025,46(6):795-799.
- [15].
张博,郭孝静,吴珊红,等.基于“脾-线粒体”探讨“强脾”治疗失神经肌萎缩[J].中医学报,2024,39(10):2042-2045.
- [16].
LEE CJM,KOSYAKOVSKY LB,KHAN MS,et al. Car-diovascular,kidney,liver,and metabolic interactions in heart failure:breaking down silos[J]. Circ Res,2025,136(11):1170-1207.
- [17].
MIRKOWSKI K,VELLONE E,Z .ÓŁKOWSKA B,et al. Frailty and heart failure: clinical insights,patient out-comes and future directions[J]. Card Fail Rev,2025,11: e05.
- [18].
NAGY D,ONÓDI Z,KOCSIS M,et al. Multiorgan characterization of inflammasome component expression in a rat model of advanced heart failure[J]. ESC Heart Fail,2025,12(5):3601-3613.
- [19].
HUANG CK,DAI DP,XIE HY,et al. Lgr4 governs a pro-inflammatory program in macrophages to antagonize post-infarction cardiac repair[J]. Circ Res,2020,127(8):953-973.
- [20].
王文炎,梁凤霞,陈瑞.基于“君火以明,相火以位”理论探析相火离位之因[J].中华中医药杂志,2019,34(10):4494-4496.
- [21].
周子千.慎斋遗书[M].孟景春,点注.南京:江苏科学技术出版社,1987: 9.
- [22].
OSTROMINSKI JW,CHENG AYY,NELSON AJ,et al. Cardiovascular,kidney,and metabolic health: an action-able vision for heart failure prevention[J]. Lancet,2025,406(10508):1171-1192.
- [23].
郭喜,翁敏,祁荟颖.慢性肾功能衰竭并肌肉减少症大鼠模型的实验研究[J].安徽医科大学学报,2024,59(8):1439-1445.
- [24].
CRUZ-JENTOFT AJ,BAHAT G,BAUER J,et al. Sarcopenia: revised European consensus on definition and diagnosis[J]. Age Ageing,2019,48(1):16-31.
- [25].
LORTIE J,RUSH B,OSTERBAUER K,et al. Myoste-atosis as a shared biomarker for sarcopenia and Cachexia using MRI and ultrasound[J]. Front Rehabil Sci,2022,3: 896114.
- [26].
GUZMÁN MENTESANA G,BÁEZ AL,LO PRESTI MS,et al. Functional and structural alterations of cardiac and skeletal muscle mitochondria in heart failure patients[J]. Arch Med Res,2014,45(3):237-246.
- [27].
王润英,梁嘉钰,李晓凤,等.基于《黄帝内经》“气交”理论探析黄芽汤[J].天津中医药大学学报,2024,43(7):577-580.
- [28].
叶天士.临证医案指南[M].苏礼,焦振廉,张琳叶,整理.北京:人民卫生出版社,2006: 387.
- [29].
郑烨,秦淮,郝如意,等.超声评估心力衰竭患者胃肠壁淤血程度的应用价值[J].中国临床新医学,2024,17(7):789-793.
- [30].
TAGLIAFICO AS,BIGNOTTI B,TORRI L,et al. Sar-copenia: how to measure,when and why[J]. Radiol Med,2022,127(3):228-237.
- [31].
SARNAIK KS,MIRZAI S. When the heart,kidneys,and body waste away: a review of Cachexia in cardiorenal syndrome[J]. Curr Heart Fail Rep,2025,22(1):23.
- [32].
CHAI J,MOHIADDIN H,MANDAL AKJ,et al. Role of open access echocardiography in detection of cardiac structural and functional abnormalities[J]. Postgrad Med J,2023,99(1170):308-312.
- [33].
陈秋艳,黄娟平,邱文芳.心脏彩超检查在不同心功能分级冠心病心力衰竭患者中的诊断价值[J].中国医学创新,2024,21(19):53-57.
- [34].
李碧茜.心脏彩超联合心电图对冠心病伴心力衰竭病情程度的诊断价值分析[J].中国现代药物应用,2024,18(17):68-71.